Attention healthcare providers!

There are three excellent online educational opportunities that can be completed for accreditation through October 31st – that’s less than 30 days from now so don’t delay!

All three activities, which take a deep dive into the recognition, treatment and management of females with bleeding disorders, are designed for practitioners who may be new to this field or who function outside the hemophilia treatment center network.

Primary care physicians, obstetrician/gynecologists, nurse/nurse practitioners, dentists, oral surgeons and other allied professionals are encouraged to take advantage of these activities, which are jointly provided by NHF, Impact Education and the Postgraduate Institute for Medicine:

An Introduction to the Recognition, Appropriate Diagnosis, and Timely Management of von Willebrand Disease and other Bleeding Disorders among Women in Non-Hematology Health Care Settings

This activity was originally supported by an independent grant from Shire as well as cooperative agreement number NU27 DD001154 funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

Advanced Considerations for the Recognition, Appropriate Diagnosis, and Timely Management of von Willebrand Disease and Other Bleeding Disorders among Women in Non-Hematology Health Care Settings

This activity was originally supported by an independent grant from Shire as well as cooperative agreement number NU27 DD001154 funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

Improving Outcomes for Females with Bleeding Disorders in Non-Hematology Health Care Settings

This activity was originally supported by an independent educational grant from Novo Nordisk, Inc. as well as cooperative agreement number NU27 DD001154 funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.